Search alternatives:
significant severity » significant diversity (Expand Search), significant benefits (Expand Search), significant event (Expand Search)
mean decrease » a decrease (Expand Search)
significant severity » significant diversity (Expand Search), significant benefits (Expand Search), significant event (Expand Search)
mean decrease » a decrease (Expand Search)
-
1
Maximum IFN concentrations are decreased in severe patients.
Published 2025“…B) Model predictions of mean values of maximal IFN concentrations in mild and severe virtual patients. Statistical differences in maximal IFN values between groups are marked by a level of significance (*) estimated based on p-values above the box plots (*, p < 0.05; **, p < 0.005; ***, p < 0.0005; ****, p < 5e-5). …”
-
2
-
3
Decrease of the mean number of natural teeth and POPs with age.
Published 2021“…<p>The number of (A) natural teeth and (B) POPs significantly decreased with age in both males and females (<i>P</i> < 0.001). …”
-
4
The number of gauging cross-sections where a statistically significant decreasing trend was identified.
Published 2024“…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.</p>…”
-
5
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
6
-
7
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
8
-
9
-
10
-
11
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
12
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
13
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
14
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
15
-
16
-
17
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
18
Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).
Published 2025“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”
-
19
-
20